{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:13:36Z","timestamp":1790313216754,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejps.2014.01.014","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T19:01:58Z","timestamp":1392750118000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Synthesis and in vitro biological evaluation of aminoacridines and artemisinin\u2013acridine hybrids"],"prefix":"10.1016","volume":"56","author":[{"given":"Juan P.","family":"Joubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissinda","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"N\u2019Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.ejps.2014.01.014_b0005","first-page":"43","article-title":"Safety: pharmacokinetics and efficacy of artemisinins in pregnancy","volume":"3","author":"Ades","year":"2011","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.ejps.2014.01.014_b0010","unstructured":"Advanced Chemistry Inc. ACD\/ChemSketch, 2000, Version 4.5."},{"key":"10.1016\/j.ejps.2014.01.014_b0015","doi-asserted-by":"crossref","first-page":"e47733","DOI":"10.1371\/journal.pone.0047733","article-title":"Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone","volume":"7","author":"Amuasi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2014.01.014_b0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1568026013395100","article-title":"Physicochemical profiling: solubility, permeability and charge state","volume":"1","author":"Avdeef","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0025","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/AAC.38.8.1753","article-title":"Antimalarial activity of WR 243251: a dihydroacridinedione","volume":"38","author":"Berman","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2014.01.014_b0030","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1124\/mol.108.045120","article-title":"Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex","volume":"73","author":"Biagini","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2014.01.014_b9010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1211\/jpp.60.2.0004","article-title":"Transport of fluoroalkyl dihydroartemisinin derivatives across rat intestinal tissue","volume":"60","author":"Bigucci","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.01.014_b0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00027-003-0672-7","article-title":"Photodegradation of pharmaceuticals in the aquatic environment: a review","volume":"65","author":"Boreen","year":"2003","journal-title":"Aquat. Sci."},{"key":"10.1016\/j.ejps.2014.01.014_b0040","first-page":"7603","article-title":"The biosynthesis of artemisinin (qinghaosu) and the phytochemistry of Artemisia annua L. (qinghao)","volume":"15","author":"Brown","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2014.01.014_b0045","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/jm060399n","article-title":"A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum","volume":"49","author":"Burgess","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0050","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/AAC.05133-11","article-title":"Design and evaluation of primaquine\u2013artemisinin hybrids as a multi-stage antimalarial strategy","volume":"55","author":"Capela","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2014.01.014_b0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1461-5347(99)00180-7","article-title":"Combined molecular lipophilicity descriptore and their role in understanding intramolecular effects","volume":"2","author":"Caron","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ejps.2014.01.014_b0060","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1021\/jm020266b","article-title":"Prediction of aqueous solubility of a diverse set of compounds using quantitative structure\u2013property relationships","volume":"46","author":"Cheng","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.18388\/abp.1997_4381","article-title":"Inhibition of mammalian topoisomerase I by 1-nitro-9-aminoacridines: dependence on thiol activation","volume":"44","author":"Ciesielska","year":"1997","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejps.2014.01.014_b0070","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.bmc.2012.06.014","article-title":"Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin","volume":"20","author":"Cloete","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0075","doi-asserted-by":"crossref","first-page":"247597","DOI":"10.1155\/2012\/247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejps.2014.01.014_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1477-3627(03)02310-9","article-title":"Haemozoin (malaria pigment): a unique crystalline drug target","volume":"2","author":"Egan","year":"2003","journal-title":"Targets"},{"key":"10.1016\/j.ejps.2014.01.014_b0085","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0090","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/37.3.511","article-title":"Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro","volume":"37","author":"Elueze","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2014.01.014_b0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4269\/ajtmh.2012.12-0025","article-title":"Artemisinin-resistant malaria: research challenges, opportunities and public health implications","volume":"87","author":"Fairhurst","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejps.2014.01.014_b0100","first-page":"1","article-title":"Access to subsidized ACT and malaria treatment-evidence from the first year of the AMFm program in six districts in Uganda","author":"Fink","year":"2013","journal-title":"Health Policy Plan."},{"key":"10.1016\/j.ejps.2014.01.014_b0105","unstructured":"Global Malaria Action Plan, 2013. <www.rbm.who.int\/gmap\/gmap.pdf> (date of access: 20.04.13)."},{"key":"10.1016\/j.ejps.2014.01.014_b0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2014.01.014_b0115","first-page":"313","article-title":"Metabolism of \u03b2-arteether to dihydroqinghaosu by human liver microsomes and ecombinant cytochrome P450","volume":"26","author":"Grace","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2014.01.014_b0120","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/jm0109816","article-title":"Design and synthesis of endoperoxide antimalarial prodrug models","volume":"45","author":"Hindley","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00232-002-1019-3","article-title":"A novel transporter, Pfcrt, confers antimalarial drug resistance","volume":"190","author":"Howard","year":"2001","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejps.2014.01.014_b0130","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/jm061371e","article-title":"Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin","volume":"50","author":"Hulsman","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jep.2013.07.040","article-title":"Antiproliferative and apoptosis inducing activity of Markhamia tomentosa leaf extract on HeLa cells","volume":"149","author":"Ibrahim","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2014.01.014_b0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1248\/cpb.49.287","article-title":"Efficient photocleavage of DNA by cationic porphyrin\u2013acridine hybrids with the effective length of diamino alkyl linkage","volume":"49","author":"Ishikawa","year":"2001","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejps.2014.01.014_b0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s002280050295","article-title":"Pharmacokinetics and bioavailability of oral and intramuscular artemether","volume":"52","author":"Karbwang","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.01.014_b0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.01.014_b0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ejps.2014.01.014_b0165","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/jm990552w","article-title":"Synthesis and antimalarial activity of artemisinin derivatives containing an amino group","volume":"43","author":"Li","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2014.01.014_b0175","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1107\/S1600536810029090","article-title":"1-Bromo-2-(10\u03b2-dihydroartemisinoxy)-ethane","volume":"66","author":"Lombard","year":"2010","journal-title":"Acta Crys. E."},{"key":"10.1016\/j.ejps.2014.01.014_b9000","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bmcl.2011.01.103","article-title":"Synthesis and antimalarial activity of artemisinin-quinoline hybrids","volume":"21","author":"Lombard","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2014.01.014_b0180","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1021\/jo00223a017","article-title":"Thermal rearrangement and decomposition products of artemisinin (qinghaosu)","volume":"50","author":"Lin","year":"1985","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0185","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/jm9607919","article-title":"Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-Substituted phenyl)-4 (R or S)-[10 (\u03b1 or \u03b2) dihydroartemisininoxy] butyric acids","volume":"40","author":"Lin","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0190","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/jm00126a017","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives: 2. Stereospecificity of the ether side chain","volume":"32","author":"Lin","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0195","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","article-title":"Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejps.2014.01.014_b0200","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","article-title":"Artemisinin: mechanisms of action, resistance and toxicity","volume":"32","author":"Meshnick","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2014.01.014_b0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejps.2014.01.014_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejps.2014.01.014_b0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","article-title":"Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"71","author":"Muregi","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejps.2014.01.014_b0220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2009.00709.x","article-title":"Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development","volume":"23","author":"Na-Bangchang","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.01.014_b0225","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/ml400164t","article-title":"Design, synthesis, and antiplasmodial activity of hybrid compounds based on (2R,3S)-N-benzoyl-3-phenylisoserine","volume":"4","author":"Njogu","year":"2013","journal-title":"ACS. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2014.01.014_b0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of Falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejps.2014.01.014_b9005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The Molecular mechanism of action of artemisinin-the debate continues","volume":"15","author":"O\u2019Neill","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2014.01.014_b0235","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bmcl.2012.12.032","article-title":"In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites","volume":"23","author":"P\u00e9rez","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2014.01.014_b0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.actatropica.2003.10.006","article-title":"Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs","volume":"89","author":"Ploypradith","year":"2004","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejps.2014.01.014_b0245","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/infdis\/jit079","article-title":"Potential of artemisinin-based combination therapies to block malaria transmission","volume":"207","author":"Price","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2014.01.014_b0250","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(96)91488-9","article-title":"Effects of artemisinin derivatives on malaria transmissibility","volume":"347","author":"Price","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2014.01.014_b0255","doi-asserted-by":"crossref","first-page":"927148","DOI":"10.1155\/2012\/927148","article-title":"Comparison and optimization of different methods for the in vitro production of Plasmodium falciparum gametocytes","volume":"2012","author":"Roncales","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.ejps.2014.01.014_b0260","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/82.13.1113","article-title":"Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay against a diverse panel of human tumor cell lines","volume":"82","author":"Rubinstein","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejps.2014.01.014_b0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.33786\/JCPR.2011.v01i03.012","article-title":"A brief review on malaria and current antimalarial drugs","volume":"1","author":"Rudrapal","year":"2011","journal-title":"Curr. Pharm. Res."},{"key":"10.1016\/j.ejps.2014.01.014_b0270","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1021\/bi034269h","article-title":"Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum","volume":"42","author":"Sanchez","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2014.01.014_b0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ardp.200700184","article-title":"Antimalarial drugs: what is in use and what is in the pipeline","volume":"341","author":"Schlitzer","year":"2008","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejps.2014.01.014_b0280","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1021\/jp104520f","article-title":"Roles of individual and cooperative motions of molecules in glass\u2013liquid transition and crystallization of toluene","volume":"114","author":"Souda","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejps.2014.01.014_b0285","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0040-4039(94)02419-C","article-title":"Synthesis and reactions of ll-azaartemisinin and derivatives","volume":"36","author":"Torok","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejps.2014.01.014_b0290","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasite in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejps.2014.01.014_b0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1874104501105010011","article-title":"Acridine and acridinones: old and new structures with antimalarial activity","volume":"5","author":"Vald\u00e9s","year":"2011","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.ejps.2014.01.014_b0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0223-5234(96)88287-0","article-title":"Antimalarial activity of new ethers and thioethers of dihydroartemisinin","volume":"30","author":"Venugopalan","year":"1995","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.01.014_b0305","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.2174\/138161209789058183","article-title":"Hybrid drugs for malaria","volume":"15","author":"Walsh","year":"2009","journal-title":"Curr. Pharm."},{"key":"10.1016\/j.ejps.2014.01.014_b0310","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","article-title":"A novel artemisinin\u2013quinine hybrid with potent antimalarial activity","volume":"17","author":"Walsh","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2014.01.014_b0315","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.1078167","article-title":"Plasmodium chloroquine resistance and the search for a replacement antimalarial drug","volume":"298","author":"Wellems","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejps.2014.01.014_b0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.exppara.2006.03.014","article-title":"Evaluation and lead optimization of anti-malarial acridones","volume":"114","author":"Winter","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejps.2014.01.014_b0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/pgmj.2004.028399","article-title":"Artemisinins","volume":"81","author":"Woodrow","year":"2005","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejps.2014.01.014_b0330","unstructured":"World Health Organization (WHO), 2011. World Malaria Report 2011. <http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241564403\/en\/index.html> (date of access: 20.04.13)."},{"key":"10.1016\/j.ejps.2014.01.014_b0335","unstructured":"World Health Organization (WHO), 2012. World Malaria Report 2012. <http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2012\/report\/en\/index.html> (date of access: 20.04.13)."},{"key":"10.1016\/j.ejps.2014.01.014_b0340","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1248\/cpb.59.984","article-title":"Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach","volume":"59","author":"Xie","year":"2011","journal-title":"Chem. Pharm. Bull. (Tokyo)"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T10:24:09Z","timestamp":1716546249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":70,"alternative-id":["S0928098714000591"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.01.014","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro biological evaluation of aminoacridines and artemisinin\u2013acridine hybrids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}